AI assistant
Sending…
Royalty Pharma plc — Director's Dealing 2023
May 23, 2023
30286_dirs_2023-05-22_adaa47a0-b09b-4bd8-88e2-31035889c450.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Royalty Pharma plc (RPRX)
CIK: 0001802768
Period of Report: 2023-05-22
Reporting Person: RIGGS RORY B (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-05-22 | Class A Ordinary Shares | S | 1750000 | $32.82 | Disposed | 6762 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Class A Ordinary Shares | 85187 | Indirect |
| Class A Ordinary Shares | 15000 | Indirect |
More from Royalty Pharma plc
Regulatory Filings
2026
May 28
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 13
Regulatory Filings
2026
Mar 19
Regulatory Filings
2026
Mar 18
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 13
Director's Dealing
2026
Feb 13